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ORIGINAL ARTICLELaparoscopic Lavage Is Feasible and Safe for the Treatment
of Perforated Diverticulitis With Purulent Peritonitis
The First Results From the Randomized Controlled Trial DILALAEva Angenete, MD, PhD, Anders Thornell, MD, Jakob Burcharth, MD, PhD,y
Hans-Christian Pommergaard, MD, PhD,y Stefan Skullman, MD, PhD,z
Thue Bisgaard, MD, DMSc,§ Per Jess, MD, PhD, Zoltan La¨ckberg, MD,jj
Peter Matthiessen, MD, PhD, Jane Heath, RN, Jacob Rosenberg, MD, DMSc,y and
Eva Haglind, MD, PhDObjective: To evaluate short-term outcomes of a new treatment for perforated
diverticulitis with purulent peritonitis in a randomized controlled trial.
Background: Perforated diverticulitis with purulent peritonitis (Hinchey III)
has traditionally been treated with surgery including colon resection and stoma
(Hartmann procedure)with considerable postoperativemorbidity andmortality.
Laparoscopic lavage has been suggested as a less invasive surgical treatment.
Methods: Laparoscopic lavagewas comparedwith colon resection and stoma
in a randomized controlled multicenter trial, DILALA (ISRCTN82208287).
Initial diagnostic laparoscopy showing Hinchey III was followed by random-
ization. Clinical data was collected up to 12 weeks postoperatively.
Results: Eighty-three patients were randomized, out of whom 39 patients in
laparoscopic lavage and 36 patients in the Hartmann procedure groups were
available for analysis. Morbidity and mortality after laparoscopic lavage did
not differ when compared with the Hartmann procedure. Laparoscopic lavage
resulted in shorter operating time, shorter time in the recovery unit, and
shorter hospital stay.
Conclusions: In this trial, laparoscopic lavage as treatment for patients with
perforated diverticulitis Hinchey III was feasible and safe in the short-term.
Keywords: diverticolitis, Hartmann, laparoscopy, lavage, morbidity Copyright © 2015 Wolters Kluw
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P erforated diverticulitis of the colon is an uncommon seriousabdominal condition, and perforation with purulent peritonitis (Hin-
chey III)1 is even more uncommon.2 The traditional treatment for this
group of patients has been open operation with resection of the inflamed
and perforated colon with a stoma, that is, the Hartmann procedure.
Considerablemorbidity has been reported after theHartmannprocedure3
andmany patients will never undergo secondary surgery with reversal of
the stoma and restored bowel continuity.4 Less invasive types of surgical
treatment have thus been considered.5–8 One such procedure is laparo-
scopy with abdominal lavage, which in a large prospective case series
reported good results.5 However, no randomized trials have yet reported
any results. As the published evidence primarily includes retrospective
series,7 the need for randomized studies is obvious.
The aim of this analysis was to compare short-term results of
laparoscopic lavage with the Hartmann procedure within a random-
ized trial ‘‘DIverticulitis—LAparoscopic LAvage vs resection (Hart-
man procedure) for acute diverticulitis with peritonitis’’ (DILALA).
METHODS
Trial Design
This trial was designed as a prospective, randomized, con-
trolled trial (1:1) of laparoscopic lavage versus open Hartmann
procedure. The protocol has previously been described in detail.9
Patients were included at 9 surgical departments in Sweden and
Denmark from February 2010 to February 2014. The reports from
this trial follow the CONSORT statement when applicable.10
Participants
Inclusion of patients was based on radiologic examination of
the abdomen showing intra-abdominal fluid or gas and a decision to
perform surgery followed by the patient’s informed consent. After
inclusion, patients were taken to the operating room and the pro-
cedures were commenced with a diagnostic laparoscopy.
The exclusion criteria were as follows: patients not possible to
operate due to concomitant disease or patients participating in
another randomized trials in conflict with the protocol and end-
points of the DILALA trial.
When the diagnostic laparoscopy of the abdomen revealed a
diverticulitis Hinchey grade III (purulent peritonitis and an inflamed
part of the colon), patients were intraoperatively randomized.
Patients with Hinchey grade I to II (no free fluid/pus in the abdomen),
Hinchey grade IV (fecal contamination), or other pathology at
laparoscopy were not eligible for randomization.er Health, Inc. All rights reserved.
www.annalsofsurgery.com | 117
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possible inclusion. The screening log was established when a hospital
entered the study. All admitted patients with a diagnosis of diver-
ticulitis according to the International Classification of Diagnosis
(ICD-10) codes K57.2, K57.3, and K57.8 who underwent surgery at
the included hospitals were registered in the screening log.
Research personnel assured that the block randomization
sequence was followed and that clinical data entered into clinical
record forms was correct. No center monitored its own data.
Interventions
Laparoscopic lavage of all 4 quadrants was performed with
saline, 3 L or more, of body temperature, until clear fluid was
returned. Open Hartmann procedure was performed through a mid-
line incision. All specimens underwent pathology examination.
A passive drainwas placed in the pelvis in all patients and left in
place for at least 24 hours. Both groups were treated postoperatively
according to local routines regarding antibiotic treatment, thrombosis
prophylaxis and return to oral feeding. Patients were excluded after
randomization because of withdrawn consent; cancer or other diag-
noses than diverticulitis at surgery or during follow-up (Fig. 1).
Outcomes
Four clinical record forms were filled out by the health care
professionals. Baseline patient information was collected at
inclusion. Details of the operative procedure as well as the post-
operative phase until discharge and follow-up until 6 to 12 weeks
were collected. All complications were reviewed in detail and Copyright © 2015 Wolters Kluw
FIGURE 1. Flowchart of patients included in the trial.
118 | www.annalsofsurgery.comretrospectively classified according to Clavien-Dindo,11 but to
reduce the risk of misclassification, grade I and II were combined.
Primary outcomeof this trialwas reoperationswithin 12months
postoperatively, which will be reported when all patients have reached
full follow-up. The present data are on short-term clinical outcomes;
morbidity, readmissions, reoperations, and mortality. Additional sec-
ondary outcomes are described in the protocol article.9
Sample Size
The DILALA trial primary end-point was reoperations within
12 months. A reduction of the need for further operations of 10% in
the group that has undergone laparoscopic lavage was considered
clinically relevant. With a statistical power of 80% and a level of
significance at 5%, randomization of 64 patients was required. Given
the relatively complicated setup for the trial and that all procedures
were emergency surgery, the inclusion was set to 80 randomized
patients (40 þ 40).
Randomization
Randomization was stratified per hospital and the patients
were randomized in blocks of 10 by a professional statistician not
involved in the trial.9 The allocation sequence was concealed from
the staff at the participating centers by using sequentially numbered
thick opaque sealed envelopes. The envelope was opened perioper-
atively after the operating surgeon had diagnosed the patient as
having a diverticulitis Hinchey grade III. The surgeon on call (often
not the local study investigator) was responsible for the perioperative
randomization.er Health, Inc. All rights reserved.
 2015 Wolters Kluwer Health, Inc. All rights reserved.
TABLE 1. Demography of the Study Population
Laparoscopic
Lavage (n¼ 39)
Hartmann’s
Procedure (n¼ 36) P
Missing Data
Lavage/Hartmann
Age 62 (18–86) 68 (35–88) 0.124
Sex (women/men) 18/21 21/15 0.292
ASA classification
0.222 2 (5.1%)/3 (8.3%)
I 7 (18.9%) 8 (24.2%)
II 22 (59.5%) 13 (39.4%)
III 8 (21.6%) 10 (30.3%)
IV 0 2 (6.1%)
BMI 25.6 (21–32) 24.9 (19–36) 0.200 8 (20.5%)/8 (22.2%)
Previous diverticulitis 5/39 (12.8%) 5/36 (13.9%) 0.892
Previous abdominal surgery 16/39 (41%) 11/36 (30.6%) 0.345
Diabetes 2/35 (5.7%) 2/30 (6.3%) 0.926 4 (10.2%)/4 (11.1%)
Cardiovascular disease 18/38 (47.4%) 15/35 (42.9%) 0.699 1 (2.6%)/1 (2.8%)
Immunosuppressants 3/35 (8.6%) 5/32 (15.6%) 0.439 4 (10.2%)/4 (11.1%)
Annals of Surgery  Volume 263, Number 1, January 2016 Laparoscopic Lavage for DiverticulitisStatistical Methods
This article explores several secondary end-points in the
DILALA trial: morbidity and mortality within 30 days as well as
mortality within 90 days. Nonparametric statistics were used, and all
results are reported as median with range or percentages in paren-
theses. Mann-Whitney U analysis, x2 test, and the Fisher exact test
were used where appropriate.
Ethical Aspects
This trial was approved by the Danish ethical committee
(Protocol nr. H-4–2009–088) and the Ethical committee in Gothen-
burg (EPN Dnr 378–09). The trial was registered at ISRCTN for
clinical trials ISRCTN82208287 (http://www.controlled-trials.com/
ISRCTN82208287).
RESULTS
The trial included 139 patients and after diagnostic laparo-
scopy 83 patients were randomized. After exclusions, there were
39 patients in the laparoscopic lavage group and 36 patients in
the open Hartmann’s group available for analysis (Fig. 1). The
screening log was returned by 6 out of 9 participating hospitals.
Demographic data are shown in Table 1, and there were no obvious
differences between the groups.
The preoperative clinical characteristics of the patients were
comparable between the 2 groups as shown in Table 2. There were no
violations of the randomization, due to technical or other reasons. The Copyright © 2015 Wolters Kluw
TABLE 2. Clinical Characteristics Preoperatively
Laparoscopic
Lavage (n¼ 3
Leukocyte count (109/L) 13.6 (4–25)
C-reactive protein (mg/L) 218 (3–530)
Body temperature (Celsius) 37.6 (36–41)
Abdominal examination
Soft abdomen and local tenderness or palpable mass 5/39 (12.8%)
Localized peritonitis 16/39 (41.0%)
Generalized peritonitis 18/39 (46.2%)
Decision base for surgery
Computed Tomography 38/39 (97.4%)
Clinical evaluation 36/38 (94.7%)
Time from decision until surgery (hh:mm) 3:05 (1:00–13:3
 2015 Wolters Kluwer Health, Inc. All rights reserved.perioperative details are reported in Table 3. Patients in the lavage
group had significantly shorter operating time, almost one and a half
hour (P< 0.0001). Therewas a difference in number of patients with a
suprapubic urinary catheter (Table 3), and overall 15.8%of the patients
in the lavage group did not need a urinary catheter compared to no
patients in the Hartmann’s group (P¼ 0.025).
Postoperative outcomes are shown in Table 4. Patients oper-
ated by laparoscopic lavage spent significantly shorter time (median
4 hours) in the recovery unit compared with the Hartmann’s group
(median 6 hours; P < 0.05). Laparoscopic lavage resulted in shorter
hospital stay (median 6 days) compared with the Hartmann’s group
(median 9 days; P < 0.05) but had a significantly longer period of
abdominal drainage (median 3 vs 2 days; P< 0.05). Mortality within
30 days (3/39 vs 0/36) and 90 days (3/39 vs 4/36) did not differ
significantly between the groups.
Reoperations and complications classified according to Clav-
ien-Dindo11 are presented in Table 5. There were no statistical
differences between the 2 groups and neither did the number of
complications per patient differ between the 2 groups. Only 2 patients
were readmitted.
DISCUSSION
The main findings of the present trial were that laparoscopic
lavage for perforated diverticulitis with purulent peritonitis (Hinchey
III) was feasible and safe. Compared with patients undergoing
Hartmann’s resection, patients treated with laparoscopic lavage wereer Health, Inc. All rights reserved.
9)
Hartmann’s
Procedure (n¼ 36) P
Missing Data
Lavage/Hartmann
13.3 (3–22) 0.953 1 (2.6%)/0
177.5 (1–460) 0.277 1 (2.6%)/0
37.9 (37–40) 0.737 4 (10.3%)/2 (5.6%
0.479
5/36 (13.9%)
12/36 (33.3%)
19/36 (52.8%)
35/35 (100%) 0.340 0/1 (2.8%)
33/34 (97.1%) 0.623 1 (2.6%)/2 (5.6%)
8) 2:51 (1:11–8:30) 0.725
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TABLE 3. Operative Data
Laparoscopic
Lavage (n¼ 39)
Hartmann’s
Procedure (n¼ 36) P
Missing Data
Lavage/Hartmann
Duration of surgery (hh:mm) 1:08 (0:28–3:14) 2:34 (0:58–4:26) <0.0001 4 (10.3%)/ 3(8.3%)
Time between end of surgery and end of anesthesia (hh:mm) 0:19 (0:05–0:42) 0:29 (0:00–1:37) <0.0001 4 (10.3%)/3 (8.3%)
Additional surgical procedure 0 2/36 (5.6%) 0.368 4 (10.3%)/ 0
Amount of saline used for lavage 0.045 0/8 (22.2%)
No lavage 0 4/28 (14.3%)
3 L 23/39 (59%) 19/28 (67.9%)
4–5 L 9/39 (23.1%) 4/28 (14.3%)
6–10 L 3/39 (7.7%) 1/28 (3.6%)
>10 L 4/39 (10.3%) 0
Inflammation site 0.295
Sigmoid colon 39/39 (100%) 35/36 (97.2%)
Rectum 0 1/36 (2.8%)
Visible perforation in the colon 2/38 (5.2%) 18/36 (50%) <0.0001 1 (2.6%)/0
Presence of adhesions 0.710
None 15/39 (38.5%) 16/36 (44.4%)
Average 20/39 (51.3%) 18/36 (50%)
Severe 4/39 (10.3%) 2/36 (5.6%)
Adhesions causing technical difficulties 8/37 (21.6%) 5/35 (14.3%) 0.419 2 (5.1%)/1 (2.8%)
Conversions from of randomization 0 0
Description of the Hartmann’s procedure
Location of the proximal resection margin
Ileumy 1/36 (2.8%)
Left colon 14/36 (38.9%)
Sigmoid colon 21/36 (58.3%)
Location of the distal resection margin
Sigmoid colon 3/36 (8.3%)
Rectosigmoid junction 28/36 (77.8%)
Rectum 5/36 (13.9%)
Drainage 37/39 (94.9%) 30/36 (83.3%) 0.106 2 (5.1%)/0
Urinary catheter
Suprapubic catheter 0/39 (0%) 5/36 (13.9%) 0.016
Transurethral catheter 32/38 (84.2%) 31/36 (86.1%) 0.818 1 (2.6%)/0
Loop ileostomy and appendectomy.
ySmall bowel adherent to the inflamed sigmoid colon. The sigmoid colon was the most proximal resection margin on the colon, but the small bowel was also resected.
Angenete et al Annals of Surgery  Volume 263, Number 1, January 2016no different in regard to overall morbidity and short-term mortality.
The patients also had shorter duration of surgery and shorter hospital
stay after laparoscopic lavage.
There are currently 4 ongoing randomized trials9,12–14 of
which this study is the first to publish results after complete accrual.
The primary endpoint of this trial is number of reoperations within 12
months, a follow-up time not yet reached for all patients. The present Copyright © 2015 Wolters Kluw
TABLE 4. Short-term Outcome Data
Laparoscopic
Lavage (n¼ 39)
Time in recovery unit, h 4 (1–12)
Required intensive care, n 5/39 (12.8%)
Number of days with drainage 3 (0–21)
Blood transfusion, n 4/39 (10.3%)
Postoperative hospital stay, d 6 (2–27)
Stoma related problems, n
Skin irritation around the ostomy N/A
Difficulties learning to care for the stoma N/A
Reoperation within 30 days, n 5/38 (13.2%)
Mortality within 30 days, n 3/39 (7.7%)
Mortality within 90 days, n 3/39 (7.7%)
Readmission within 30 days, n 0/38
More than 1 readmission within 30 days, n 0/38
120 | www.annalsofsurgery.comarticle reports short-term data within 30 days after operation and
mortality within 90 days.
Patients undergoing laparoscopic lavage had significantly
shorter duration of surgery probably reflecting the less extensive
surgical procedure, but it may also somewhat be due to the con-
version in the Hartmann’s resection group. These patients both had a
laparoscopic and an open procedure performed.er Health, Inc. All rights reserved.
Hartmann’s
Procedure (n¼ 36) P Missing Data
6 (2–44) 0.045 5 (12.8%)/4 (11.1%)
4/36 (11.1%) 0.802
2 (0–17) 0.021 1 (2.6%)/7 (19.4%)
2/36 (5.6%) 0.453
9 (4–36) 0.037 1 (2.6%)/2 (5.6%)
5/36(13.9%)
11/36 (30.6%)
6/35 (17.1%) 0.634 1 (2.6%)/1 (2.8%)
0/36 (0%) 0.094
4/36 (11.4%) 0.583
2/35 (5.7%) 0.135 1 (2.6%)/1 (2.8%)
1/35 (5.7%) 0.294 1 (2.6%)/1 (2.8%)
 2015 Wolters Kluwer Health, Inc. All rights reserved.
TABLE 5. Details on Complications and Reoperations
Laparoscopic Lavage Hartmann’s Procedure P Missing Data
Complications
Classification according to Clavien-Dindo
Grade I and II 17/38 (44.7%) 13/35 (37.1%) 0.510 1 (2.6%)/1 (2.8%)
Grade IIIa 3/38 (7.9%) 0/35 (0%) 0.090 1 (2.6%)/1 (2.8%)
Grade IIIb 4/38 (10.5%) 2/25 (5.7%) 0.455 1 (2.6%)/1 (2.8%)
Grade IVa 3/38 (7.9%) 3/35 (8.6%) 0.916 1 (2.6%)/1 (2.8%)
Grade IVb 1/38 (2.6%) 1/35 (2.9%) 0.953 1 (2.6%)/1 (2.8%)
Grade V 0 0 1 (2.6%)/1 (2.8%)
No. complications per patient
1 7/38 (18.4%) 5/35 (14.3%) 1 (2.6%)/1 (2.8%)
2 8/38 (21.1%) 7/35 (20%) 1 (2.6%)/1 (2.8%)
3 1/38 (2.6%) 1/35 (2.9%) 1 (2.6%)/1 (2.8%)
4 2/38 (5.3%) 1/35 (2.9%) 1 (2.6%)/1 (2.8%)
5 2/38 (5.3%) 0/35 (0%) 1 (2.6%)/1 (2.8%)
Reoperation within 30 days, n 5/38 (13.2%) 6/35 (17.1%) 0.634 1 (2.6%)/1 (2.8%)
Type of reoperation
Intra-abdominal abscess 2 1
Retained drainage (required laparoscopy) 1 0
Perforation of the colon (Hinchey IV) 1 0
Suspicion of bleeding 1 0
Stoma complication 0 2
Persistent peritonitis (no new findings after surgery)y 0 1
Haematoma (and inguinal hernia) 0 1
Sepsis 0 1
A patient can have more than one complication. Five patients in the laparoscopy group and seven patients in the Hartmann’s procedure group had more than one Clavien-Dindo 1
and 2 complication.
yNot considered a complication as the patient did not have any sign of complication during the re-laparotomy
Annals of Surgery  Volume 263, Number 1, January 2016 Laparoscopic Lavage for DiverticulitisAfter laparoscopic lavage, there was no need for stoma care
training, which in part may explain the shorter hospital stay. This will
be part of the estimation of health care costs, which will be analyzed
after the 12 months’ follow-up.
Diagnostic laparoscopy was feasible in the majority of the
patients, and only 4% of the procedures could not be performed due
to technical difficulties or severe intra-abdominal inflammation. In
patients randomized to laparoscopic lavage the procedure was feas-
ible in all. We found no differences in overall outcomes such as
complications or mortality pointing at laparoscopic lavage as a safe
alternative to Hartmann’s procedure. Mortality after Hartmann’s
procedure has been reported to be 5.7% to 24%,2,4 which is com-
parable to our results of 11.4%. Previous reviews have reported
considerably lower mortality rates of 1.4% to 1.7% after laparoscopic
lavage.7,15 However, these series may be subject to selection bias
underestimating mortality rates and it is possible that our mortality
rate after laparoscopic lavage of 7.7% probably more closely reflect
the true rate in daily clinical practice. Fewer colonic perforations
were reported in the laparoscopic lavage group, which probably is
due to that the protocol did not require visualization during laparo-
scopy to define a Hinchey grade III. The handling of the inflamed
colon during an open Hartmann’s procedure rather than a more
advanced disease in the Hartmann’s group would be the explanation
of the higher rate of visible perforation.
The strengths of this trial were its multicenter randomized
design and the fact that the majority of the participating hospitals
had screening logs to detect possible selection bias. In our trial, we
randomized patients after initial diagnostic laparoscopy to avoid
including patients with other diagnoses. The LADIES study also used
initial diagnostic laparoscopy before randomization but has stopped
accrual for laparoscopic lavage due to safety issues.12,16 The Lap-
LANDaswell as the SCANDIV study 13,14 randomizes patients before
laparoscopy, which may result in the inclusion of patients with other
diagnoses.Another important strength in our trialwas that all statistical Copyright © 2015 Wolters Kluw
 2015 Wolters Kluwer Health, Inc. All rights reserved.analyses were performed as planned beforehand with no post hoc
subgroup analysis. We consider the fact that we had 9 participating
hospitals from2 countries as a strength leading to an increased external
validity of the results comparedwith a single center design. The design
of the trial did not require any special training for the surgeons, which
also enhances the external validity of our results.
One limitation of this trial was the relatively large number of
patients potentially possible to include but not enrolled due to various
reasons. However, the reasons for noninclusion of possible candi-
dates were such that no obvious selection bias seems to have been
present. Rather the reasons were, as expected in a trial dealing with
emergency conditions, difficulties regarding logistics. Another
limitation was that there was no general agreement upon classifi-
cation of complications at the time of the design of the study. Later,
the Clavien-Dindo classification11 has been widely used but it was
not recognized in early 2009 when this protocol was written. This is
compensated in part as reoperations and readmissions were reported
in the CRF but we also retrospectively classified all complications
according to the Claiven-Dindo classification, but of course there is a
risk of misinterpretations, especially regarding grade I and II. It may
also be mentioned that the analyses were not adjusted for multiple
testing, thus low P values should be regarded as interesting findings
rather than conclusive evidence.
Our results may have widespread implications in daily clinical
practice when treating patients with complicated diverticulitis. There
seems to be an international trend toward not resecting the sigmoid
colon even after multiple attacks of diverticulitis, due to a limited risk
of perforation after recurrence.17 However, when peritonitis is
present, it has until now been the routine to perform Hartmann’s
procedure. If the long-term results of the present trial together with
the results of the other randomized trials support the safety of
laparoscopic lavage, then hopefully patients may avoid colon resec-
tion and stoma creation and hence some of the well-known short- and
long-term complications.3er Health, Inc. All rights reserved.
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Laparoscopic lavage in Hinchey III–perforated diverticulitis
was feasible and in the short-term as safe as Hartmann’s procedure.
We suggest that widespread implementation of the technique should
await long-term results from the ongoing randomized trials.ACKNOWLEDGMENTS
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